301087 可孚医疗
已收盘 03-19 15:00:00
资讯
新帖
简况
3月19日可孚医疗跌5.32%,国泰金鹰增长混合基金重仓该股
证券之星 · 03-19 16:16
3月19日可孚医疗跌5.32%,国泰金鹰增长混合基金重仓该股
海清智元、可孚医疗、璞泰来、思谋科技递表港交所;蚂蚁集团收购耀才证券金融获批丨港交所早参
每日经济新闻 · 03-18 07:06
海清智元、可孚医疗、璞泰来、思谋科技递表港交所;蚂蚁集团收购耀才证券金融获批丨港交所早参
可孚医疗(301087)披露H股上市申请材料更新公告,3月17日股价下跌3.1%
证券之星 · 03-17 22:35
可孚医疗(301087)披露H股上市申请材料更新公告,3月17日股价下跌3.1%
可孚医疗冲刺港股:年营收34亿,利润3.7亿 已获IPO备案
雷递网 · 03-17 08:49
可孚医疗冲刺港股:年营收34亿,利润3.7亿 已获IPO备案
可孚医疗科技股份有限公司向港交所提交上市申请书
每日经济新闻 · 03-16
可孚医疗科技股份有限公司向港交所提交上市申请书
新股消息 | 可孚医疗(301087.SZ)二次递表港交所
智通财经 · 03-16
新股消息 | 可孚医疗(301087.SZ)二次递表港交所
中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期
智通财经 · 03-16
中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期
可孚医疗:公司暂无相关合作和计划
证券之星 · 03-12
可孚医疗:公司暂无相关合作和计划
可孚医疗:截至2026年3月10日,公司股东总户数约1.7万户
证券之星 · 03-11
可孚医疗:截至2026年3月10日,公司股东总户数约1.7万户
【私募调研记录】盘京投资调研可孚医疗
证券之星 · 03-11
【私募调研记录】盘京投资调研可孚医疗
可孚医疗:公司已与皇家飞利浦达成战略合作,获得其大中华区家庭健康监测相关品类的品牌授权
证券之星 · 03-10
可孚医疗:公司已与皇家飞利浦达成战略合作,获得其大中华区家庭健康监测相关品类的品牌授权
可孚医疗:公司目前主要通过战略投资方式布局该领域
证券之星 · 03-10
可孚医疗:公司目前主要通过战略投资方式布局该领域
图解可孚医疗年报:第四季度单季净利润同比增长86.17%
证券之星 · 03-10
图解可孚医疗年报:第四季度单季净利润同比增长86.17%
可孚医疗(301087)披露2025年年度报告,3月9日股价上涨0.34%
证券之星 · 03-09
可孚医疗(301087)披露2025年年度报告,3月9日股价上涨0.34%
可孚医疗最新公告:公司发行境外上市外资股(H股)获得中国证监会备案
证券之星 · 03-09
可孚医疗最新公告:公司发行境外上市外资股(H股)获得中国证监会备案
可孚医疗获IPO备案:9个月营收24亿净利2.6亿 张敏夫妇控制54%股权
雷递网 · 03-07
可孚医疗获IPO备案:9个月营收24亿净利2.6亿 张敏夫妇控制54%股权
股市必读:可孚医疗(301087)3月2日董秘有最新回复
证券之星 · 03-03
股市必读:可孚医疗(301087)3月2日董秘有最新回复
可孚医疗:截至2026年2月27日,公司股东总户数约1.7万户
证券之星 · 03-02
可孚医疗:截至2026年2月27日,公司股东总户数约1.7万户
股市必读:可孚医疗(301087)2月24日董秘有最新回复
证券之星 · 02-25
股市必读:可孚医疗(301087)2月24日董秘有最新回复
可孚医疗:截至2026年2月13日,公司股东总户数约1.7万户
证券之星 · 02-24
可孚医疗:截至2026年2月13日,公司股东总户数约1.7万户
加载更多
公司概况
公司名称:
可孚医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-10-25
主营业务:
可孚医疗科技股份有限公司的主营业务是医疗器械研发、生产、销售和服务。公司的主要产品是血糖尿酸监测系列、血压计、血氧仪、体温计、胎心仪、居家检测试纸、矫正/矫姿系列、助听器、轮椅、护理床、助行器、移位机、听力计、敷贴/敷料系列、健康防护系列、感染防控系列、成人护理系列、造口护理系列、呼吸机、制氧机、雾化器、便携制氧器、鼻腔护理、理疗仪、膏贴、拔罐、针灸针、按摩器、艾叶及制成品、刮痧板。
发行价格:
93.09
{"stockData":{"symbol":"301087","market":"SZ","secType":"STK","nameCN":"可孚医疗","latestPrice":55.73,"timestamp":1773903789000,"preClose":58.86,"halted":0,"volume":3828611,"delay":0,"changeRate":-0.0532,"floatShares":194000000,"shares":209000000,"eps":2.0655,"marketStatus":"已收盘","change":-3.13,"latestTime":"03-19 15:00:00","open":58.31,"high":58.56,"low":55.58,"amount":217000000,"amplitude":0.0506,"askPrice":55.74,"askSize":20,"bidPrice":55.73,"bidSize":18,"shortable":0,"etf":0,"ttmEps":2.0655,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773970200000},"marketStatusCode":5,"adr":0,"adjPreClose":58.86,"symbolType":"stock","openAndCloseTimeList":[[1773883800000,1773891000000],[1773896400000,1773903600000]],"highLimit":64.75,"lowLimit":52.97,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":208897000,"isCdr":false,"pbRate":2.53,"roa":"--","peRate":26.98136,"roe":"7.69%","epsLYR":1.83,"committee":0.097345,"marketValue":11642000000,"turnoverRate":0.0197,"status":1,"floatMarketCap":10814000000},"requestUrl":"/m/hq/s/301087","defaultTab":"news","newsList":[{"id":"2620210958","title":"3月19日可孚医疗跌5.32%,国泰金鹰增长混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620210958","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620210958?lang=zh_cn&edition=full","pubTime":"2026-03-19 16:16","pubTimestamp":1773908185,"startTime":"0","endTime":"0","summary":"证券之星消息,3月19日可孚医疗跌5.32%,收盘报55.73元,换手率1.97%,成交量3.83万手,成交额2.17亿元。重仓可孚医疗的前十大公募基金请见下表:该股最近90天内共有4家机构给出评级,买入评级4家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共15家,其中持有数量最多的公募基金为国泰基金的国泰金鹰增长混合。该公募基金现任基金经理为徐治彪。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900025592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301087"],"gpt_icon":0},{"id":"2620401887","title":"海清智元、可孚医疗、璞泰来、思谋科技递表港交所;蚂蚁集团收购耀才证券金融获批丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2620401887","media":"每日经济新闻","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620401887?lang=zh_cn&edition=full","pubTime":"2026-03-18 07:06","pubTimestamp":1773788772,"startTime":"0","endTime":"0","summary":"|2026年3月18日星期三|NO.1海清智元、可孚医疗、璞泰来、思谋科技递表港交所据港交所3月16日消息,深圳海清智元科技股份有限公司(以下简称海清智元)、可孚医疗科技股份有限公司(以下简称可孚医疗,SZ301087)、上海璞泰来新能源科技集团股份有限公司(以下简称璞泰来,SH603659)、SmartMoreInc.(思谋科技)已向港交所主板递交上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603183675062222.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"18b3ef6975ebbd699cc2ad2acd327cd9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603183675062222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0224","603659","BK0155","BK1147","IE0005HP3H50.USD","301087","BK0214","BK0251","06688","BK0186","SG9999001069.SGD"],"gpt_icon":1},{"id":"2620475369","title":"可孚医疗(301087)披露H股上市申请材料更新公告,3月17日股价下跌3.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620475369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620475369?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:35","pubTimestamp":1773758118,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘,可孚医疗报收于58.86元,较前一交易日下跌3.1%,最新总市值为122.96亿元。该股当日开盘60.88元,最高61.81元,最低58.73元,成交额达2.24亿元,换手率为1.93%。公司于近日披露《关于申请发行境外上市外资股(H股)并上市的进展公告》。公告显示,可孚医疗科技股份有限公司已于2025年8月29日向香港联交所递交发行境外上市外资股(H股)的申请,并于2026年3月6日获得中国证监会出具的境外发行上市备案通知书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301087"],"gpt_icon":0},{"id":"2620415454","title":"可孚医疗冲刺港股:年营收34亿,利润3.7亿 已获IPO备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2620415454","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620415454?lang=zh_cn&edition=full","pubTime":"2026-03-17 08:49","pubTimestamp":1773708581,"startTime":"0","endTime":"0","summary":"可孚医疗科技股份有限公司(简称:“可孚医疗”)更新招股书,准备在港交所上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260317/6390933417284033002317924.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260317/6390933417284033002317924.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32909/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["301087","VXUS"],"gpt_icon":0},{"id":"2620546445","title":"可孚医疗科技股份有限公司向港交所提交上市申请书","url":"https://stock-news.laohu8.com/highlight/detail?id=2620546445","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620546445?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:49","pubTimestamp":1773665340,"startTime":"0","endTime":"0","summary":"每经AI快讯,3月16日,港交所显示,可孚医疗科技股份有限公司向港交所提交上市申请书,联席保荐人为华泰国际、BNP PARIBAS。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260316/c675328788.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260316/c675328788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2619634094","title":"新股消息 | 可孚医疗(301087.SZ)二次递表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2619634094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619634094?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:47","pubTimestamp":1773665222,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据港交所3月16日披露,可孚医疗科技股份有限公司(简称:可孚医疗,301087.SZ)向港交所主板递交上市申请,华泰国际、法国巴黎银行为其联席保荐人。这是该公司第二次递表港交所,此前曾于2025年8月29日递交过上市申请。招股书显示,可孚医疗是中国最大的家用医疗器械企业之一。根据弗若斯特沙利文的资料,按2024年的国内收入计,公司在中国所有家用医疗器械企业中排名第二,市场份额达2.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414527.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301087","HEXmain","BK0251"],"gpt_icon":0},{"id":"2619458178","title":"中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2619458178","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619458178?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:05","pubTimestamp":1773648327,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中银国际发布研报称,近日,国家药监局批准博睿康植入式脑机接口手部运动功能代偿系统创新产品注册申请,实现脑机接口全球首发上市,标志中国脑机接口产业从“技术验证”迈向“商业化落地”。投资建议随着全球首款侵入式产品获批上市,国内脑机接口产业已进入商业化验证期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中银国际:全球首款侵入式脑机产品获批 行业迈入商业化验证期","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688580","BK0251","301363","688273","BK0114","BK0096","300753","301293","688626","002173","BK0077","BK0236","301087"],"gpt_icon":0},{"id":"2618180193","title":"可孚医疗:公司暂无相关合作和计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2618180193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618180193?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:42","pubTimestamp":1773308538,"startTime":"0","endTime":"0","summary":"证券之星消息,可孚医疗(301087)03月12日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,注意到公司在布局AI制药相关方面,也注意到公司在和泓博医药有AI制药AI大模型相关的合作,泓博医药可以说是国内AI制药第一股,现在市值这么低潜力这么巨大,公司为什么不直接控股或者收购呢可孚医疗回复:尊敬的投资者,您好。公司暂无相关合作和计划,感谢您的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200030983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2618415609","title":"可孚医疗:截至2026年3月10日,公司股东总户数约1.7万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2618415609","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618415609?lang=zh_cn&edition=full","pubTime":"2026-03-11 19:18","pubTimestamp":1773227889,"startTime":"0","endTime":"0","summary":"证券之星消息,可孚医疗(301087)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布截至昨天3月10的公司股东户数信息。谢谢!致礼!可孚医疗回复:尊敬的投资者,您好。截至2026年3月10日,公司股东总户数约1.7万户,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100033860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2618998043","title":"【私募调研记录】盘京投资调研可孚医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2618998043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618998043?lang=zh_cn&edition=full","pubTime":"2026-03-11 08:12","pubTimestamp":1773187920,"startTime":"0","endTime":"0","summary":"根据市场公开信息及3月10日披露的机构调研信息,知名私募盘京投资近期对1家上市公司进行了调研,相关名单如下:1)可孚医疗 (盘京投资参与公司特定对象调研&电话会议)调研纪要:2026 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260311/c675206576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2618720935","title":"可孚医疗:公司已与皇家飞利浦达成战略合作,获得其大中华区家庭健康监测相关品类的品牌授权","url":"https://stock-news.laohu8.com/highlight/detail?id=2618720935","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618720935?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:42","pubTimestamp":1773135729,"startTime":"0","endTime":"0","summary":"证券之星消息,可孚医疗(301087)03月10日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司产品AI端侧业务落地进展情况如何?飞利浦高端授权产品落地情况如何?谢谢可孚医疗回复:尊敬的投资者,您好。公司已与皇家飞利浦达成战略合作,获得其大中华区家庭健康监测相关品类的品牌授权。目前双方正加快研发协同、产品取证与上市筹备工作,后续将依托公司全渠道及供应链优势,稳步推进高端产品市场化落地。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000027569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2618357169","title":"可孚医疗:公司目前主要通过战略投资方式布局该领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2618357169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618357169?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:42","pubTimestamp":1773135726,"startTime":"0","endTime":"0","summary":"证券之星消息,可孚医疗(301087)03月10日在投资者关系平台上答复投资者关心的问题。投资者提问:请问贵公司是否有涉及脑机接口的相关领域?可孚医疗回复:尊敬的投资者,您好。公司目前主要通过战略投资方式布局该领域,相关布局尚处于早期阶段,短期内不会对公司经营业绩产生重大影响。敬请广大投资者理性决策,注意投资风险。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000027564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2618730016","title":"图解可孚医疗年报:第四季度单季净利润同比增长86.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618730016","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618730016?lang=zh_cn&edition=full","pubTime":"2026-03-10 01:12","pubTimestamp":1773076327,"startTime":"0","endTime":"0","summary":"证券之星消息,可孚医疗2025年年报显示,当年度公司主营收入33.87亿元,同比上升13.56%;归母净利润3.72亿元,同比上升19.2%;扣非净利润2.98亿元,同比上升8.33%;其中2025年第四季度,公司单季度主营收入9.9亿元,同比上升34.79%;单季度归母净利润1.11亿元,同比上升86.17%;单季度扣非净利润7597.4万元,同比上升35.01%;负债率26.04%,投资收益1584.46万元,财务费用-298.75万元,毛利率53.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000000701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087"],"gpt_icon":0},{"id":"2618624721","title":"可孚医疗(301087)披露2025年年度报告,3月9日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618624721","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618624721?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:10","pubTimestamp":1773065436,"startTime":"0","endTime":"0","summary":"截至2026年3月9日收盘,可孚医疗报收于59.25元,较前一交易日上涨0.34%,最新总市值为123.77亿元。该股当日开盘58.47元,最高62.07元,最低57.8元,成交额达2.9亿元,换手率为2.53%。近日,可孚医疗科技股份有限公司披露2025年年度报告摘要。公司2025年末总资产为6,628,915,230.03元,同比增长3.21%;归属于上市公司股东的净资产为4,866,857,736.11元,同比增长1.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900035054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301087"],"gpt_icon":0},{"id":"2618623883","title":"可孚医疗最新公告:公司发行境外上市外资股(H股)获得中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2618623883","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618623883?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:29","pubTimestamp":1773055791,"startTime":"0","endTime":"0","summary":"可孚医疗(301087.SZ)公告称,公司已收到中国证监会出具的《关于可孚医疗科技股份有限公司境外发行上市备案通知书》,公司拟发行不超过42,393,600股境外上市普通股并在香港联交所主板挂牌上市。备案通知书主要内容包括公司拟发行股数、重大事项报告要求、发行上市后的报告义务、更新备案材料的时间要求等。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900029372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2617365605","title":"可孚医疗获IPO备案:9个月营收24亿净利2.6亿 张敏夫妇控制54%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2617365605","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617365605?lang=zh_cn&edition=full","pubTime":"2026-03-07 08:34","pubTimestamp":1772843643,"startTime":"0","endTime":"0","summary":"可孚医疗科技股份有限公司(简称:“可孚医疗”)日前获IPO备案,拿到了上市的钥匙。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260307/6390846921770000132397463.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260307/6390846921770000132397463.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32809/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["301087"],"gpt_icon":0},{"id":"2616473352","title":"股市必读:可孚医疗(301087)3月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2616473352","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616473352?lang=zh_cn&edition=full","pubTime":"2026-03-03 01:18","pubTimestamp":1772471890,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,可孚医疗报收于58.2元,上涨0.78%,换手率1.71%,成交量3.32万手,成交额1.92亿元。董秘最新回复投资者: 您好,截止到2月底公司的股东人数是多少?截至2026年2月27日,公司股东总户数约1.7万户,感谢您的关注!未来随着全球化战略的持续深化推进,公司海外业务收入占比有望稳步提升。当日关注点来自交易信息汇总:3月2日主力资金净流入2357.3万元,显示主力对个股短期关注度提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300000715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2616339606","title":"可孚医疗:截至2026年2月27日,公司股东总户数约1.7万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616339606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616339606?lang=zh_cn&edition=full","pubTime":"2026-03-02 19:51","pubTimestamp":1772452265,"startTime":"0","endTime":"0","summary":"证券之星消息,可孚医疗(301087)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,截止到2月底公司的股东人数是多少?谢谢!可孚医疗回复:尊敬的投资者,您好。截至2026年2月27日,公司股东总户数约1.7万户,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200034156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"gpt_icon":0},{"id":"2614635741","title":"股市必读:可孚医疗(301087)2月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614635741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614635741?lang=zh_cn&edition=full","pubTime":"2026-02-25 01:44","pubTimestamp":1771955054,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘,可孚医疗报收于54.38元,下跌3.32%,换手率1.69%,成交量3.28万手,成交额1.8亿元。董秘最新回复投资者: 请问最新一期公司的股东人数是多少?截至2026年2月13日,公司股东总户数约1.7万户,感谢您的关注!交易信息汇总资金流向2月24日主力资金净流出99.3万元;游资资金净流出816.66万元;散户资金净流入915.96万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500000982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301087"],"gpt_icon":0},{"id":"2613307792","title":"可孚医疗:截至2026年2月13日,公司股东总户数约1.7万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2613307792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613307792?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:12","pubTimestamp":1771927928,"startTime":"0","endTime":"0","summary":"证券之星消息,可孚医疗(301087)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问:请问最新一期公司的股东人数是多少?谢谢可孚医疗回复:尊敬的投资者,您好。截至2026年2月13日,公司股东总户数约1.7万户,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400034804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773959846959,"stockEarnings":[{"period":"1week","weight":-0.0959},{"period":"1month","weight":-0.0092},{"period":"3month","weight":0.216},{"period":"6month","weight":0.4326},{"period":"1year","weight":0.6071},{"period":"ytd","weight":0.2476}],"compareEarnings":[{"period":"1week","weight":-0.0297},{"period":"1month","weight":-0.0185},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0488},{"period":"1year","weight":0.1693},{"period":"ytd","weight":0.0095}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"可孚医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"17000人(较上一季度增加0.30%)","perCapita":"11414股","listingDate":"2021-10-25","address":"湖南省长沙市雨花区环保东路一段87号","registeredCapital":"20889万元","survey":" 可孚医疗科技股份有限公司的主营业务是医疗器械研发、生产、销售和服务。公司的主要产品是血糖尿酸监测系列、血压计、血氧仪、体温计、胎心仪、居家检测试纸、矫正/矫姿系列、助听器、轮椅、护理床、助行器、移位机、听力计、敷贴/敷料系列、健康防护系列、感染防控系列、成人护理系列、造口护理系列、呼吸机、制氧机、雾化器、便携制氧器、鼻腔护理、理疗仪、膏贴、拔罐、针灸针、按摩器、艾叶及制成品、刮痧板。","listedPrice":93.09},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"可孚医疗(301087)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供可孚医疗(301087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"可孚医疗,301087,可孚医疗股票,可孚医疗股票老虎,可孚医疗股票老虎国际,可孚医疗行情,可孚医疗股票行情,可孚医疗股价,可孚医疗股市,可孚医疗股票价格,可孚医疗股票交易,可孚医疗股票购买,可孚医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"可孚医疗(301087)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供可孚医疗(301087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}